Edesa Biotech, Inc. (EDSA): Operatsion rentabellik

Ommaviy kompaniya Edesa Biotech Corp (EDSA) logotipi

Edesa Biotech, Inc. (EDSA) kompaniyasining choraklik operatsion marjasi o'ziga xos antitelalardan foydalangan holda o'tkir pnevmoniyani davolash uchun mo'ljallangan biotexnologik ekotizimning samaradorligini ko'rsatadi. Oxirgi ko'rsatkich 0.00 ni tashkil etadi, bu esa kelajakdagi dermatologik dori vositalaridan kutilayotgan daromadlarni tahlil qilishda muhim ahamiyatga ega. Joriy o'sish samarali immunologik yechimlarga o'tkir ehtiyoj mavjud bo'lgan intensiv terapiya markazlarining yuqori talabi bilan bog'liq.

EDSA: Edesa Biotech Inc Operatsion marja 04.07.2022 - 19.11.2026

Edesa Biotech, Inc. (EDSA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning dastlabki tahlili:EDSA, edesabiotech.com
Edesa Biotech Corp tayyor mahsulotlari

Ichki ishlanmalar va grant moliyalashtirishga e'tibor qaratadigan Edesa Biotech, Inc. (EDSA) uchun operatsion marja soliqlar va foizlar to'lanishidan oldin barcha ishlab chiqarish xarajatlari chegirib tashlanganidan keyin qolgan daromad qismini aks ettiradi. Operatsion foyda marjalarining tahlili birlashmalar mavjud bo'lmagan holatda resurslarni boshqarish samaradorligini baholash imkonini beradi, bunda barqaror egri chiziq biofarmatsevtika biznesining turli tadqiqot bosqichlaridagi moliyaviy barqarorligini tasdiqlaydi.

Edesa Biotech, Inc. raqobatchilari

ARGX (argenx N.V.) - Operatsion marja|Sotuvning operatsion rentabelligi BioNTech Pharma BNTX|Sotuvning operatsion marjasi ABVX (ABIVAX)|Operatsion marja ADMA Biologics, Inc. (ADMA)|Operatsion marja PTGX (protagonist-inc.com)|IMVT: Operatsion foyda bo'yicha sotuv rentabelligi|KNSA - Operatsion rentabellik|GRFS: Operatsion rentabellik|ADPT (Adaptive Biotechnologies) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha sotuv rentabelligi CLDX|Sotuvning operatsion marjasi AUPH|BCRX (BioCryst Pharmaceuticals) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operatsion foyda normasi|Pharvaris N.V. - Sotuvning operatsion marjasi|Operatsion foyda normasi ABCL|TRML: Sotuvning operatsion marjasi|PGEN (Precigen) - Operatsion foyda bo'yicha sotuv rentabelligi|pharming.com (PHAR) - Operatsion rentabellik|Nektar Corp (NKTR) - Operatsion marja|UPB (upstreambio.com) - Operatsion marja|ZBIO: Operatsion foyda normasi|Operatsion marja IMNM|Operatsion faoliyat rentabelligi Gossamer Bio Inc|Operatsion marja KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Operatsion foyda marjasi|PVLA: Sotuvning operatsion marjasi|Operatsion foyda marjasi SVRA|RIGL: Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ANAB|ATXS (Astria Corp) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ENGN (enGene Bio)|Operatsion marja RAPT|Operatsion faoliyat rentabelligi Aerovate Therapeutics|Operatsion rentabellik Aclaris Therapeutics Inc. ACRS|Operatsion faoliyat rentabelligi Kyverna Therapeutics Inc. (KYTX)|TLSA - Operatsion rentabellik|CABA: Operatsion rentabellik|VTYX (Ventyx Biosciences, Inc.) - Sotuvning operatsion marjasi|THTX - Operatsion faoliyat rentabelligi|AVTX (avalotx.com) - Operatsion marja|Sotuvning operatsion rentabelligi Eledon Pharmaceuticals Inc. ELDN|Operatsion marja AGEN|CLYM (Climb Bio, Inc.) - Operatsion foyda normasi|Operatsion rentabellik zurabio.com ZURA|ATYR - Sotuvning operatsion marjasi|Adagene Inc - Operatsion marja|ImageneBio (IMA) - Sotuvning operatsion marjasi|Shattuck Therapeutics (STTK) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Equillium Inc (EQ)|Sotuvning operatsion marjasi CNTB|Operatsion foyda bo'yicha sotuv rentabelligi IMUX (Immunic, Inc.)|Operatsion rentabellik Atara Biotherapeutics, Inc. (ATRA)|IFRX - Sotuvning operatsion rentabelligi|Operatsion faoliyat rentabelligi XFOR|Operatsion faoliyat rentabelligi Adicet (ACET)|CELU - Operatsion rentabellik|INMB (INmune Bio, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|BRNS: Operatsion marja|Kezar Life Sciences Inc. (KZR) - Operatsion marja|Operatsion rentabellik SAB Biotherapeutics Inc|Operatsion marja Akari Therapeutics, Plc|Operatsion rentabellik Enlivex Therapeutics Ltd (ENLV)|QTTB - Sotuvning operatsion rentabelligi|Operatsion marja GOVX (GeoVax Corp)|Operatsion faoliyat rentabelligi iBio (IBIO)|CARM - Operatsion rentabellik|XTL Biopharmaceuticals (XTLB) - Sotuvning operatsion marjasi|BOLT: Operatsion marja|Sotuvning operatsion marjasi HCW Biologics Inc.|Operatsion rentabellik Aptevo|Operatsion foyda bo'yicha sotuv rentabelligi AIM (AIM ImmunoTech, Inc.)|Operatsion marja ADTX|Operatsion faoliyat rentabelligi GRI Bio Corp|Operatsion marja XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Sotuvning operatsion rentabelligi|Revelation Biosciences Corp - Operatsion marja|INDP (Indaptus Therapeutics, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|SCNI: Operatsion marja|CALI - Operatsion faoliyat rentabelligi|AFMD (Affimed N.V.) - Operatsion marja|Operatsion rentabellik ALLK|Sotuvning operatsion marjasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Sotuvning operatsion rentabelligi|Operatsion rentabellik iTeos ITOS|Ocean Bio - Operatsion rentabellik|TC BioPharm Ltd - Operatsion marja|Sotuvning operatsion rentabelligi thirdharmonicbio.com